IFN-γ drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (11)
Papers in which this entity is mentioned.
- Nanopore-based cell-free DNA fragmentation and methylation profiles from the cerebral spinal fluid of patients with lung cancer brain metastases. (2025)
- Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. (2023)
- Osteoclasts in Osteosarcoma: Mechanisms, Interactions, and Therapeutic Prospects. (2023)
- Macrophage Polarization States in the Tumor Microenvironment. (2021)
- Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. (2020)
- ASEP: Gene-based detection of allele-specific expression across individuals in a population by RNA sequencing. (2020)
- Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer. (2019)
- Best practices for bioinformatic characterization of neoantigens for clinical utility. (2019)
- The Immune Landscape of Cancer. (2018)
- Altered maternal immune networks are associated with adverse child neurodevelopment: Impact of alcohol consumption during pregnancy. (2018)
- Ewing sarcoma protein: a key player in human cancer. (2013)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| ifn-γ | drug | 35 | 99 |